(NYSE: STE) Steris's forecast annual revenue growth rate of 7.12% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Steris's revenue in 2024 is $5,407,384,000.On average, 3 Wall Street analysts forecast STE's revenue for 2025 to be $576,717,937,432, with the lowest STE revenue forecast at $575,865,468,752, and the highest STE revenue forecast at $577,627,322,996.
In 2026, STE is forecast to generate $607,394,062,899 in revenue, with the lowest revenue forecast at $605,025,688,109 and the highest revenue forecast at $611,876,267,527.